Shirakawa et al.
JOCFeatured Article
(s, 1 H). 13C NMR (125 MHz, CDCl3) δ 21.8, 21.9, 30.7, 33.7,
39.0, 43.7, 52.0, 52.1, 56.1, 56.3, 113.2, 113.3, 116.2, 117.8,
122.1, 124.3, 125.1, 125.3, 126.5, 126.6, 127.8, 128.0, 131.4,
131.5, 131.98, 132.01, 135.67, 135.72, 157.4, 157.9, 166.9,
167.2, 170.3, 170.8. HRMS (ESI) calcd for C17H19NO4:
[M þ Na]þ, 324.1212. Found: m/z 324.1194.
4.76/4.69 (s, 2 H), 7.18/7.06 (d, J = 2.4/2.3 Hz, 1 H), 7.13/7.15
(t, J = 7.5/7.5 Hz, 1 H), 7.21/7.24 (t, J = 7.6/7.6 Hz, 1 H), 7.37/
7.41 (d, J = 8.1/8.2 Hz, 1 H), 7.72/7.53 (d, J = 7.9/7.9 Hz, 1 H),
8.18/8.29 (bs, 1 H).
N-Methyl-N-[(5-pentyl-2-furyl)methyl]acetamide (4dw). A pale
yellow oil. Observed as two rotamers of 52/48 ratio in 1H
NMR. 1H NMR (500 MHz, CDCl3) δ 0.85-0.94 (m, 3 H),
1.27-1.38 (m, 4 H), 1.61/1.61 (quint, J = 7.3/7.3 Hz, 2 H), 2.22/
2.10 (s, 3 H), 2.57/2.57 (t, J = 7.6/7.6 Hz, 2 H), 2.98/2.93 (s, 3 H),
4.36/4.51 (s, 2 H), 5.90/5.89 (d, J = 3.1/2.9 Hz, 1 H), 6.08/6.11 (d,
J = 3.1/2.9 Hz, 1 H). 13C NMR (125 MHz, CDCl3) δ 13.92,
13.94, 21.5, 21.8, 22.30, 22.33, 27.5, 27.6, 27.9, 28.0, 31.29, 31.30,
33.2, 35.4, 43.3, 47.6, 105.18, 105.24, 108.4, 108.8, 148.0, 149.0,
156.4, 156.9, 170.3, 170.7. HRMS (ESI) calcd for C13H21NO2:
[M þ Na]þ, 246.1465. Found: m/z 246.1475.
N-[(6-Bromo-2-methoxy-1-naphthyl)methyl]-N-methylacetamide
(4dr). A brownish solid. Observed as two rotamers of 87/13 ratio
in 1H NMR. 1H NMR (500 MHz, CDCl3) δ 2.09/2.39 (s, 3 H),
2.72/2.60 (s, 3 H), 3.96/3.95 (s, 3 H), 5.12/4.91 (s, 2 H), 7.29/7.31
(d, J= 9.1/8.7 Hz, 1 H), 7.53/7.56 (d, J= 9.2/9.2 Hz, 1 H), 7.72/7.76
(d, J = 9.1/8.7 Hz, 1 H), 7.91/7.96 (s, 1 H), 8.02/7.79 (d, J = 9.2/9.3
Hz, 1 H). 13C NMR (125 MHz, CDCl3) δ 21.8, 21.9, 30.7, 33.8, 39.0,
43.7, 56.2, 56.5, 113.7, 113.8, 116.4, 117.2, 117.6, 118.1, 123.8, 126.2,
127.9, 129.0, 129.5, 130.0, 130.2, 130.4, 130.5, 130.7, 131.9, 132.0,
156.17, 156.23, 170.3, 170.7. HRMS (ESI) calcd for C15H16BrNO2:
[M þ Na]þ, 344.0262. Found: m/z 344.0250.
N-Methyl-N-[(2,4,6-trimethoxyphenyl)methyl]acetamide (4dx).
A white solid. Observed as two rotamers of 80/20 ratio in
1
1H NMR. H NMR (500 MHz, CDCl3) δ 2.26/2.05 (s, 3 H),
N-[(2-Methoxy-1-naphthyl)methyl]-N-methylacetamide (4ds).
A white solid. Observed as two rotamers of 82/18 ratio in
2.70/2.70 (s, 3 H), 3.78/3.77 (s, 6 H), 3.803/3.799 (s, 3 H), 4.43/
4.61 (s, 2 H), 6.11/6.11 (s, 2 H). 13C NMR (125 MHz, CDCl3) δ
21.4, 22.1, 31.1, 33.7, 38.0, 42.1, 55.2, 55.3, 55.5, 55.7, 90.2, 90.3,
104.9, 105.4, 159.7, 160.0, 160.9, 161.1, 170.0, 170.7. HRMS
(ESI) calcd for C13H19NO4: [M þ Na]þ, 276.1206. Found: m/z
276.1203.
1
1H NMR. H NMR (500 MHz, CDCl3) δ 2.11/2.42 (s, 3 H),
2.73/2.63 (s, 3 H), 3.966/3.959 (s, 3 H), 5.17/4.96 (s, 2 H), 7.29/
7.30 (d, J = 8.4/8.4 Hz, 1 H), 7.35/7.37 (t, J = 7.6/7.6 Hz,
1 H), 7.50/7.52 (t, J = 7.4/7.4 Hz, 1 H), 7.78/7.82 (d, J =
8.2/8.2 Hz, 1 H), 7.83/7.87 (d, J = 9.0/9.0 Hz, 1 H), 8.11/7.92
(d, J = 8.7/8.7 Hz, 1 H). 13C NMR (125 MHz, CDCl3) δ 21.9,
22.0, 30.6, 33.6, 39.0, 43.7, 56.1, 56.4, 112.7, 112.8, 115.9, 117.6,
121.9, 123.5, 123.7, 124.0, 127.1, 127.2, 128.1, 128.75, 128.82,
129.0, 129.9, 130.3, 133.3, 133.4, 155.9, 156.0, 170.4 (broad).
HRMS (ESI) calcd for C15H17NO2: [M þ Na]þ, 266.1151.
Found: m/z 266.1138.
2,4-Bis(N-acetyl-N-methylaminomethyl)-1,3,5-trimethoxyben-
zene (4dx00). A white solid. Each component was observed as a
set of 2-4 peaks in 1H NMR due to existence of 3 rotamers. 1H
NMR (500 MHz, CDCl3) δ2.06/2.07/2.27/2.28 (s, 6 H), 2.68/2.69/
2.70 (s, 6 H), 3.64/3.66 (s, 3 H), 3.817/3.824/3.830 (s, 6 H), 4.45/
4.46/4.65/4.66 (s, 4 H), 6.28/6.29 (s, 1 H). 13C NMR (125 MHz,
CDCl3) δ 21.5, 22.0, 22.1, 31.15, 31.17, 33.68, 33.71, 38.5, 38.6,
43.0, 55.5, 55.6, 55.71, 55.74, 62.2, 62.6, 63.1, 91.29, 91.31,
91.5, 109.9, 110.1, 110.3, 110.5, 159.4, 159.6, 159.7, 159.86,
159.90, 160.3, 160.7, 170.2, 170.3, 170.7, 170.8. HRMS (ESI) calcd
for C17H26N2O5: [M þ Na]þ, 361.1734. Found: m/z 361.1727.
N-[1-(1-Methyl-3-indolyl)ethyl]acetamide (4gu). A brownish
solid. 1H NMR (500 MHz, CDCl3) δ 1.63 (d, J = 6.8 Hz, 3 H),
1.96 (s, 3 H), 3.76 (s, 3 H), 5.46 (quint, J = 6.8 Hz, 1 H), 5.68 (bs,
1 H), 6.99 (s, 1 H), 7.13 (t, J = 7.4 Hz, 1 H), 7.26 (t, J = 7.6 Hz,
1 H), 7.31 (d, J = 8.2 Hz, 1 H), 7.65 (d, J = 7.9 Hz, 1 H).
13C NMR (125 MHz, CDCl3) δ 20.5, 23.5, 32.7, 41.9, 109.4,
116.7, 119.3, 119.5, 122.1, 126.0, 126.3, 137.3, 169.0. HRMS (ESI)
calcd for C13H16N2O: [M þ Na]þ, 239.1155. Found: m/z 239.1165.
N-[1-(2,4,6-Trimethoxyphenyl)ethyl]acetamide (4gx). A col-
orless oil. Observed as two rotamers of 94/6 ratio in 1H NMR.
1H NMR (500 MHz, CDCl3) δ 1.34/1.45 (d, J = 6.8/6.8 Hz, 3
H), 1.93/2.04 (s, 3 H), 3.79/3.79 (s, 3 H), 3.84/3.83 (s, 6 H), 5.76/
5.18 (dq, J = 9.5, 6.8/10.3, 6.8 Hz, 1 H), 6.13/6.12 (s, 2 H), 6.83/
6.83 (d, J=8.8/8.8 Hz, 1 H). 13C NMR (125 MHz, CDCl3) δ
20.9, 21.2, 23.6, 28.5, 29.6, 40.2, 44.2, 55.2, 55.6, 55.7, 90.7, 91.0,
111.2, 111.6, 157.9, 158.3, 160.1, 160.3, 168.5 (broad). HRMS
(ESI) calcd for C13H19NO4: [M þ Na]þ, 276.1206. Found: m/z
276.1203.
N-[(2-Methoxy-5-methylphenyl)methyl]-N-methylacetamide
(4dt). A pale yellow oil. Observed as two rotamers of 62/38
ratio in 1H NMR. 1H NMR (500 MHz, CDCl3) δ 2.13/2.15 (s,
3 H), 2.28/2.26 (s, 3 H), 2.93/2.95 (s, 3 H), 3.81/3.79 (s, 3 H),
4.46/4.59 (s, 2 H), 6.78/6.76 (d, J = 8.4/8.2 Hz, 1 H), 6.85/6.99
(s, 1 H), 7.06/7.02 (d, J = 8.4/8.2 Hz, 1 H). 13C NMR (125
MHz, CDCl3) δ 20.47, 20.52, 21.3, 21.8, 33.6, 35.9, 45.0, 49.7,
55.2, 55.4, 110.1, 110.3, 124.2, 125.1, 127.6, 128.6, 128.8, 129.8, 129.86,
129.89, 155.0, 155.5, 170.7, 171.3. HRMS (ESI) calcd for C12H17NO2:
[M þ Na]þ, 230.1157. Found: m/z 230.1143.
Iron-Catalyzed Oxidative Coupling of Alkylamides with Arenes
Using the Amides as Solvents (Table 4). To a solution of FeCl3
(4.1 mg, 25 μmol) in an amide (1, 1.0 mL) in a 20 mL Schlenk
tube were added successively an arene (3, 0.25 mmol) and
t-BuOOt-Bu (140 μL, 0.75 mmol). After stirring at 120 °C for the
time specified in Table 4, the reaction mixture was diluted with
CHCl3-MeOH (9:1, 100 mL) and passed through a pad of SiO2.
Evaporation of the solvent and the amide followed by purification
with PTLC (SiO2) gave the corresponding coupling products (4). The
products were further purified with GPC if necessary.
N-Methyl-N-[(1-methyl-3-indolyl)methyl]acetamide (4du).28
1
A yellow oil. Observed as two rotamers of 65/35 ratio in H
NMR. 1H NMR (500 MHz, CDCl3) δ 2.11/2.26 (s, 3 H), 2.91/
2.98 (s, 3 H), 3.76/3.78 (s, 3 H), 4.73/4.67 (s, 2 H), 7.04/6.91 (s,
1 H), 7.12/7.14 (t, J = 7.3/7.5 Hz, 1 H), 7.24/7.25 (t, J = 7.9/8.3
Hz, 1 H), 7.30/7.33 (d, J = 8.3/8.2 Hz, 1 H), 7.70/7.52
(d, J = 7.9/8.1 Hz, 1 H). 13C NMR (125 MHz, CDCl3) δ 21.5,
21.9, 32.6, 32.7, 33.2, 34.9, 41.4, 46.6, 109.1, 109.5, 110.0, 110.6,
118.5, 119.2, 119.4, 119.5, 121.7, 122.0, 126.5, 126.6, 127.3,
128.5, 137.0, 137.2, 170.1, 173.9. HRMS (ESI) calcd for
C13H16N2O: [M þ Na]þ, 239.1155. Found: m/z 239.1154.
N-(3-Indolylmethyl)-N-methylacetamide (4dv).29 A pale yel-
low oil. Observed as two rotamers of 65/35 ratio in 1H NMR. 1H
NMR (500 MHz, CDCl3) δ 2.12/2.26 (s, 3 H), 2.91/2.99 (s, 3 H),
N-Ethyl-N-[(1-methyl-3-indolyl)methyl]acetamide (4hu).Abrown-
1
1
ish oil. Observed as two rotamers of 64/36 ratio in H NMR. H
NMR (500 MHz, CDCl3) δ 1.15/1.12 (t, J = 7.1/7.1 Hz, 3 H), 2.13/
2.21 (s, 3 H), 3.27/3.47 (q, J = 7.1/7.1 Hz, 2 H), 3.76/3.77 (s, 3 H),
4.73/4.66 (s, 2 H), 7.05/6.89 (s, 1 H), 7.12/7.14 (t, J= 7.4/7.4 Hz, 1 H),
7.23/7.27 (t, J = 7.6/7.6 Hz, 1 H), 7.29/7.33 (d, J = 8.3/
8.2 Hz, 1 H), 7.68/7.52 (d, J = 7.8/8.0 Hz, 1 H). 13C NMR (125
MHz, CDCl3) δ 12.8, 13.5, 21.5, 21.8, 32.6, 32.8, 38.4, 40.2, 41.5,
44.1, 109.1, 109.5, 110.6, 111.0, 118.5, 119.26, 119.33, 119.4, 121.7,
122.1, 126.6, 127.0, 127.4, 128.6, 136.9, 137.3, 169.8, 170.3. HRMS
(ESI) calcd for C14H18N2O: [M þ Na]þ, 253.1311. Found: m/z
253.1302.
N-Methyl-N-[1-(1-methyl-3-indolyl)ethyl]acetamide (4hu0).
This product could not be isolated in a pure form. The fol-
lowing data were obtained from spectra of a mixture with 4hu
(28) Ikeda, K.; Morimoto, T.; Sekiya, M. Chem. Pharm. Bull. 1980, 28,
1178–1182.
(29) Pedras, M. S. C.; Minic, Z.; Jha, M. FEBS J. 2008, 275, 3691–3705.
J. Org. Chem. Vol. 76, No. 1, 2011 33